Pharmafile Logo
Pharmafocus logo
Advanced Search
vxxxxeer

Russia becomes world’s first country to grant regulatory approval for a coronavirus vaccine

August 11, 2020
Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus

President Putin has announced that Russia is the first country to grant regulatory approval for a COVID-19 vaccine. The final …

News
christine

Dr Christine Wilkinson Blanc appointed as Chief Medical Officer at Nordic Nanovector

August 10, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector has announced that Dr Christine Wilkinson Blanc has been appointed as the Chief Medical Officer of the company.

Appointment
droxtchcc

Over 100 Americans have died after taking hydroxychloroquine in the first half of 2020

August 10, 2020
Sales and Marketing COVID-19, chloroquine, coronavirus, hydroxychloroquine

More than 100 Americans have died after taking the drug hydroxychloroquine to treat or prevent coronavirus. This was found in …

News
vxxxxeer

Over a third of Americans say they won’t take a coronavirus vaccine

August 10, 2020
Sales and Marketing COVID-19, coronavirus, vaccines

35% of Americans say they have no plans to take a COVID-19 vaccine, according to new polling. A new Gallup …

News
novavax

Novavax inks deal to deliver one billion COVID-19 vaccine doses in India and other regions

August 10, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, India, Novavax, Serum Institute of India Private Limited, Vaccine

Novavax is partnering up with the Serum Institute of India Private Limited (SIIPL) in a licensing deal to development and …

News
fda

FDA approves opioid Olinvyk for patients with acute pain

August 10, 2020
Sales and Marketing opioid crisis, opioids

The FDA has approved Olinvyk for the management of moderate to severe pain in adult patients when their pain is …

News
fdaoutsideweb

Genentech’s Evrysdi becomes first FDA-approved oral treatment for spinal muscular atrophy

August 10, 2020
Sales and Marketing Evrysdi, FDA, Genentech, Roche, spinal muscular atrophy

Genentech’s Evrysdi (risdiplam) has secured FDA approval for the treatment of spinal muscular atrophy (SMA), making it the first oral therapy …

News
vaccination-1215279_960_720

Early promise from Novavax’s vaccine candidate for COVID-19

August 7, 2020
Medical Communications, Research and Development COVID-19, Novavax, Vaccine

New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used …

News
covid_innovations_bamc

Researchers at the University of Oxford have said hydroxychloroquine could still be a viable COVID-19 treatment

August 7, 2020
Medical Communications COVID, hydroxychloroquine

Researchers at the University of Oxford have said that hydroxychloroquine could be beneficial to COVID-19 patients, despite a general lack …

News
astrazeneca_building_white

AstraZeneca seals manufacturing deal to deliver COVID-19 vaccine in China

August 7, 2020
Manufacturing and Production, Medical Communications AstraZeneca, COVID-19, China, pharma

AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, …

News
50185852257_94002eda8f_b

Trump signs executive order to direct federal agencies to prioritise purchasing drugs made in the US

August 7, 2020
Manufacturing and Production, Medical Communications, Sales and Marketing FDA, Peter Navarro, Trump, drug prices

US President Donald Trump has signed an executive order which will direct federal agencies to prioritise buying drugs and drug …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 7, 2020
Medical Communications COVID-19, Top 10 news, top 10

The top ten news stories this week are dominated by corporate scandals, with researchers finding that Coca-Cola paid an organisation …

News
astrazeneca_plaque

AstraZeneca’s Fasenra has strong Phase 3 showing in severe eosinophilic asthma

August 6, 2020
Research and Development AstraZeneca, Fasenra, asthma

AstraZeneca took the opportunity at the American Thoracic Society 2020 Virtual International Conference to unveil positive new Phase 3b data …

News
novartis_side_building

Novartis’ Xolair scores European approval to treat chronic rhinosinusitis with nasal polyps

August 6, 2020
Sales and Marketing Novartis, Xolair, rhinosinusitis

Novartis has snapped up approval from the European Commission for its anti-immunoglobulin E (IgE) antibody therapy Xolair (omalizumab) for the …

News
800px-european_commission_flags

European Commission approves first drug for hepatitis D

August 6, 2020
Business Services EC, hepatitis C, hepatitis D

The European Commission has approved Heplcudex (bulvirtide) as the first hepatitis D drug. It was jointly developed by researchers at …

News
j_and_j

US to pay Johnson and Johnson $1 billion for COVID-19 vaccine

August 6, 2020
Business Services COVID-19, J&J, JJ, Johnson and Johnson, coronavirus

The US will pay Johnson and Johnson more than $1 billion to create 100 million doses of COVID-19 vaccine. The …

News
800px-kodak_colorplus_200_135_film_cartridge_and_box

US Democrats probe Trump administration’s $765 million loan to Kodak to produce drug ingredients

August 6, 2020
Business Services

Democratic members of Congress are set to investigate the Trump administration’s $765 million federal loan awarded to Kodak as it …

News
morris

Humanigen appoints Timothy Morris as Chief Operating Officer and Chief Financial Officer

August 5, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Humanigen have appointed Timothy E. Morris to its newly created role of Chief Operating Officer and Chief Financial Officer and …

Appointment
nice_new_london_office_internal_3_web

NICE rejects mycosis fungoides-type cutaneous T-cell lymphoma therapy over data concerns

August 5, 2020
Research and Development, Sales and Marketing Ledaga, NICE, lymphoma

NICE has announced its rejection of Ledaga (chlormethine gel), a topical therapy for the treatment of mycosis fungoides-type cutaneous T-cell …

News
800px-nhs_nnuh_entrance

NICE advises GPs to stop prescribing opioids for chronic pain

August 5, 2020
Business Services, Research and Development COVID-19, coronavirus

The National Institutes of Health and Care Excellence has released its first guideline on the treatment of chronic pain and …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026